OneMedNet Corp
ONMD Nasdaq· Services-Commercial Physical & Biological Research
Last close · Oct 26, 2026
$4.47
KIRA · Stoqly’s AI analyst, in plain words
- OneMedNet Corp had $1.4M of revenue in fiscal 2025, up 111.4% on the year before.
- Its operating margin was −711.3%, up 782.4 pts: of every 100 in sales, about −711 is left after running the business.
- OneMedNet Corp lost $2.8M in fiscal 2025.
- Free cash flow was −$7.5M in fiscal 2025, −553.1% of revenue.
- OneMedNet Corp owes $0.6M more than it holds in cash.
Market cap
$259M
P/E
—
Revenue
$1.4M
Net income
−$2.8M
Free cash flow
−$7.5M
Operating margin
−711.3%
OneMedNet Corp in 30 seconds · fiscal 2025
Are sales growing?
+111.4%
Yes. Sales grew 111.4% last year.
Does it make a profit?
−206.1%
No. It lost money last year.
Does profit turn into cash?
−553.1%
No. It spent more cash than it brought in.
How healthy are the accounts?
5 / 9
Mixed. It passes 5 of 9 health tests.
How is the share priced?
—
No P/E: it made no profit over the last four quarters.
What OneMedNet Corp does
No business description yet.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K · Mar 30, 2026
- Legal name
- OneMedNet Corp
- CIK
- 0001849380
OneMedNet Corp · ONMD
Results and finances
The last 4 fiscal years. Amounts in USD.
| Fiscal year | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|
| Sales and profit | ||||
| Revenue | $1.2M | $1.0M | $0.6M | $1.4M |
| Revenue growth | — | −11.4% | −37.0% | 111.4% |
| Gross margin | −31.2% | −12.6% | −43.7% | −37.0% |
| Operating margin | −669.1% | −671.2% | −1,493.8% | −711.3% |
| Net income | −$30.5M | −$33.8M | −$10.1M | −$2.8M |
| Net margin | −2,641.0% | −3,308.5% | −1,575.3% | −206.1% |
| Diluted EPS | −$7.66 | −$4.65 | −$0.36 | −$0.06 |
| Cash | ||||
| Cash from operations | −$4.7M | −$4.8M | −$7.0M | −$7.5M |
| Capital expenditure | $0.1M | $0.0M | $0.1M | $0.0M |
| Free cash flow | −$4.8M | −$4.8M | −$7.0M | −$7.5M |
| FCF margin | −412.9% | −473.6% | −1,089.1% | −553.1% |
| Share count change | — | 83.0% | 286.1% | 58.7% |
| Debt and strength | ||||
| Cash and short-term investments | $0.3M | $0.0M | $0.2M | $0.6M |
| Debt incl. finance leases | — | $0.9M | $4.6M | $1.2M |
| Shareholders' equity | −$26.4M | −$13.4M | −$16.0M | −$3.0M |
| Current ratio | 0.0x | 0.0x | 0.2x | 0.4x |
| Interest coverage | −19.1x | −623.0x | −65.3x | −144.3x |
| Returns and quality | ||||
| Piotroski F-score | — | 4 | 4 | 5 |
| Altman Z'' | −317.9 | −933.2 | −134.5 | −197.3 |
Insiders bought, 12 months
$4.2M
3 insiders
Insiders sold, 12 months
$0.2M
2 insiders
Of sales under plans
0%
$0.0M
How to read these numbers
- Revenue:
- Total sales reported in the income statement.
- Operating margin:
- Operating income as a share of revenue.
- Net income:
- Profit after all expenses, interest and tax.
- Free cash flow:
- Cash from operations minus capital spending.
- Net debt / EBITDA:
- Years of EBITDA needed to pay off net debt. Below zero means more cash than debt.
- Return on capital:
- After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
OneMedNet Corp · ONMD
Charts and comparison
Ten years at a glance, and how it stacks up against similar companies.
Revenue
Net income
Margins, % of revenue
Cash vs debt (incl. leases)
Free cash flow
Dividends and buybacks
KIRA
At $4.47 a share, the company is worth $259M.
Source: SEC EDGAR XBRL filings (CIK 0001849380). Data updated October 24, 2026. For information only — not investment advice. Check the original filings before relying on any figure.